Genexine, Foreigners Net Sell 15,679 Shares... Stock Price -2.43%
Genexine has ranked among the top searched stocks for 9 days in the past month.
As of 12:31 PM on the 10th, Genexine is trading at 96,400 KRW, down 2.43% from the previous day. This represents a 10.16% decrease compared to February 18. Genexine is known as a company specializing in the development of biopharmaceuticals.
Today, foreigners are tentatively recorded as net sellers of 15,679 shares. Over the past 5 days, individual investors have net sold 61,168 shares, while foreigners and institutions have net bought 55,337 shares and 10,017 shares, respectively.
On March 2, Genexine was a market topic with the headline "Strong performance on news of COVID vaccine clinical trials."
Hot Picks Today
Given Grants, Then Says "No Launch" ... Innovative Korean Technology Ultimately Forced Overseas
- "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- [Breaking] Chairman Park Sookeun: "Possibility of Agreement Instead of Samsung Electronics Labor-Management Mediation Proposal"
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Cheaper Than Candy, Yet Impossible to Find... Fears of a 'Pediatric Medical Crisis' as Pharmaceutical Companies Halt Production [Why&Next]](https://cwcontent.asiae.co.kr/asiaresize/307/2026051910065268365_1779152813.jpg)
